Objective: To report on the FDA's Complete Response Letter regarding CTx-1301 for ADHD. Key Findings: The FDA's feedback was limited to specific CMC information
Objective: To report the FDA approval of ensitrelvir for postexposure prophylaxis of COVID-19. Key Findings: Ensitrelvir reduced the risk of symptomatic COVID-1
Objective: To investigate whether iris color influences the efficacy of low-dose atropine in myopia management. Key Findings: Safety-related ocular effects of l
Objective: To introduce the eye-light® device for managing ocular surface diseases (OSD) and dry eye. Key Findings: Eye-light® has shown greater improvements in
Objective: To summarize recent developments in biopharmaceutical approvals and collaborations. Key Findings: LYTENAVA could be the first FDA-approved ophthalmic
Objective: To reflect the significance of specimens in understanding health and guiding healing as stated by Jessica Luna. Key Findings: No key findings reporte
Objective: To evaluate the effectiveness of long-read whole genome sequencing (WGS) in identifying genetic variants linked to unexplained infertility and recurr
Objective: To discuss the role of pharmacokinetic modeling in addressing gaps in drug use during pregnancy and its implications for dosing and research. Key Fin
Objective: To investigate the significance of ZNF25 as a potential biomarker across various cancers and to elucidate its molecular mechanisms, particularly in g
Objective: To report an unusual case of tonsillar adenoid cystic carcinoma (TACC) with a 47-year disease trajectory. Key Findings: The patient exhibited a prolo
Objective: To identify serum metabolite differences at baseline that may predict fracture risk in Black individuals with Type 2 Diabetes Mellitus (T2D). Key Fin
Objective: To synthesize current knowledge on how sepsis-driven gut dysbiosis compromises intestinal barrier integrity and contributes to sepsis-associated acut
Sepsis-associated acute kidney injury (SA-AKI) has a high incidence of 40% to 50% and a mortality rate up to 70% in ICU patients.
Gut dysbiosis during sepsis leads to compromised intestinal barrier integrity, allowing bacterial products to enter circulation and activate systemic inflammation.
Specific microbial signatures linked to AKI include increased Clostridium asparagiforme and decreased Roseburia spp., along with elevated uremic toxin-producing bacteria.
Gut-derived metabolites like indoxyl sulfate and trimethylamine N-oxide promote renal inflammation and fibrosis, contributing to kidney injury.
Therapeutic strategies targeting the gut microbiota, such as fecal microbiota transplantation and probiotic supplementation, may offer new treatment avenues for SA-AKI.
Objective: To summarize current findings on how modulation of the gut microbiota may improve intestinal thermotolerance and strengthen barrier function, providi
Objective: To develop and validate a CT-based habitat radiomics model for predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma patients
A CT-based habitat radiomics model was developed to predict immunochemotherapy outcomes in EGFR-mutant lung adenocarcinoma after TKI resistance.
The study included 475 patients, with 332 in the training cohort and 143 in the validation cohort, utilizing K-means clustering for tumor subregion analysis.
The combined model achieved an AUC of 0.904 in the training cohort and 0.890 in the validation cohort, outperforming other predictive models.
Kaplan–Meier analysis indicated significant survival differences, with high-risk groups showing shorter overall survival in both cohorts.
The model's high negative predictive value suggests potential to reduce unnecessary treatments in predicted non-responders, warranting further validation.
Objective: To report two pediatric cases of severe Mycoplasma pneumoniae pneumonia (MPP) complicated by massive pleural effusion and to explore the diagnostic u
Mycoplasma pneumoniae pneumonia can lead to massive pleural effusion in 1%-20% of pediatric cases, requiring careful clinical management.
Targeted next-generation sequencing identified macrolide-resistant Mycoplasma pneumoniae and Torque teno virus in pleural effusion of two children.
Both pediatric patients recovered after closed thoracic drainage and adjusted anti-mycoplasma therapy based on resistance findings.
Torque teno virus detection in pleural fluid remains uncertain in clinical significance and may indicate immune perturbation rather than pathogenicity.
Broader pathogen testing in pleural fluid could enhance diagnostic evaluation in complex infections, warranting further controlled studies.
Objective: To examine the relationship between colorism, skin tone trauma, and eating disorders (ED) among BIPOC populations, focusing on specific cultural fact
Objective: To examine experiences of discrimination based on sexual orientation at the intersection of LGB+ and disability identities among medical students. Ke
Objective: To examine the association between immigration status and time to access the flash glucose monitoring (FGM) system among Ontario residents with insul
Flash glucose monitoring (FGM) systems improve diabetes management by reducing hemoglobin A1c levels and self-monitoring blood glucose needs.
In Ontario, FGM systems were added to the Ontario Drug Benefit formulary in 2019, providing coverage for eligible insulin-requiring diabetes patients.
Barriers to accessing FGM systems exist for immigrants, particularly those recently arrived, due to financial constraints and lack of familiarity with the health system.
Individuals with lower income levels face additional out-of-pocket costs and information gaps that hinder their access to publicly funded drug programs.
The study aimed to investigate the impact of immigration status on the time taken to access FGM systems among eligible Ontario residents.